Aclarion Inc (NAS:ACON)
$ 2.8052 +0.17 (+6.18%) Market Cap: 6.91 Mil Enterprise Value: 6.51 Mil PE Ratio: 0 PB Ratio: 0.35 GF Score: 26/100

Aclarion Inc at SRAX Sequire Biotechnology Conference (Virtual) Transcript

Feb 02, 2023 / 06:30PM GMT
Release Date Price: $108539.92 (+2.35%)
Jeff Thramann
Aclarion, Inc. - Executive Chairman & Director

Thanks. Hello, everyone. My name is Jeff Thramann. I'm the Executive Chairman of Aclarion. A little bit about my background: I'm a neurosurgeon, fellowship training in spine surgery. I got into business back in 2008 when I invented a new way to help fuse the spine together. I built a big medical device company around that, which I eventually sold to a public company.

I am a serial entrepreneur. I've done six healthcare companies now, taking them all from zero to exit, and I'm a named inventor on over 130 different patents. So I came to Aclarion as a Board member a few years back and then took the company public onto NASDAQ as I built a team.

And we are now a healthcare technology company that is leveraging MR spectroscopy biomarkers and an augmented intelligence algorithm to help optimize the treatment of disease. So it's a platform technology using MR spectroscopy. And our initial focus is really on low back pain. And we're going after low back pain because it's really a large market. It's the number-one cost diagnosis

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot